In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxter Acquires Gambro, Becomes Integrated Renal Therapy Leader

Executive Summary

Baxter’s offer of $4 billion for Swedish hemodialysis manufacturer Gambro may be one of the largest medtech acquisitions of the year, but Baxter CEO Bob Parkinson describes the deal as a bolt-on for Baxter’s existing market in renal therapy. Of course the magnitude of the deal makes it “an adjacency with a capital A”, Parkinson quipped.

Advertisement

Related Content

Real World Data Solutions For Pharma’s Looming EBIT Crisis
Device/Diagnostics Quarterly Deal Statistics, Q4 2012
Device Trends To Watch In 2013
The Medical Device Industry Stays The Course In 2012
Renal Devices: New Blood Revitalizes Dialysis Industry
NxStage: Bringing Dialysis Home
The Cardio-Renal Connection

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003784

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel